Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients

Completed · Phase 4 · Has a placebo group

Conditions studied: Reperfusion Injury

In brief

It has been shown that the stress that occurs during cardiac surgery leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to complications after surgery. This study will investigate the effects of high doses of intravenous (IV) Vitamin C on the outcome and complications after cardiac surgery.

Key facts

Study ID

NCT01167569

Run by

Rutgers, The State University of New Jersey

People needed

57

Starts

2007-10-01

Expected to finish

2013-04-01

Last updated by the study team

2020-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients 18 years or older undergoing elective or urgent (prior to hospital discharge) cardiac surgery.

You may not qualify if…

• History of renal insufficiency, nephrolithiasis, G6PD (glucose-6-phosphate dehydrogenase deficiency) or the chronic use of steroids.

Where it is running

• Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.